Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Publication Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Objectives of this study were to develop a population pharmacokinetic (PopPK) model for tacrolimus in…CertaraJune 1, 2014
The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Publication The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach CertaraMay 27, 2014
Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Publication Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Model-based meta-analysis of dose response is a sophisticated method to guide dose and regimen selection.…CertaraMay 21, 2014
Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Publication Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Although both POPPK and physiologically based pharmacokinetic (PBPK) models can account for age and other covariates within…CertaraMay 1, 2014
Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Publication Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Model-based drug development in oncology is still lagging despite a good momentum in the clinical…CertaraApril 1, 2014
Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results Publication Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results The motesanib phase III MONET1 study failed to show improvement in overall survival (OS) in…CertaraApril 1, 2014
Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Publication Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Azithromycin's extensive distribution to proinflammatory cells, including peripheral blood mononuclear cells (PBMCs) and polymorphonuclear cells…CertaraMarch 5, 2014
Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetics Studies: Which Measure of Variability Should be Used? Publication Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetics Studies: Which Measure of Variability Should be Used? A new approach for calculation of sample size in pediatric clinical pharmacokinetic studies was suggested based on desired precision for a pharmacokinetic parameter…CertaraMarch 1, 2014
Population Pharmacokinetic Analysis of Axitinib in Healthy Volunteers Publication Population Pharmacokinetic Analysis of Axitinib in Healthy Volunteers Axitinib is a potent and selective second generation inhibitor of vascular endothelial growth factor receptors…CertaraFebruary 21, 2014
A Model-based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-malignant Pain Publication A Model-based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-malignant Pain Pain is a major symptom in many medical conditions which can be relieved thanks to…CertaraFebruary 13, 2014